Abstract
The clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure is assessed through a systematic review and economic evaluation.
Original language | English |
---|---|
Pages (from-to) | 261-268 |
Number of pages | 8 |
Journal | International Journal of Technology Assessment in Health Care |
Volume | 23 |
Issue number | 2 |
DOIs | |
Publication status | Published - Apr 2007 |
Keywords
- Cost-Benefit Analysis
- Great Britain
- Heart Failure
- Humans
- Randomized Controlled Trials as Topic
- Self-Help Devices
- Treatment Outcome
- Ventricular Dysfunction, Left